Qualitest Pharmaceuticals Inc., facing a class-action lawsuit brought by the federal government and 48 states claiming unlawful labeling, has settled the case for five million dollars.
Qualitest, a manufacturer of generic vitamins and a subsidiary of Endo Health Solutions, allegedly misrepresented the amount of fluoride in its multivitamin tablets. Although Qualitest labeled and advertised its product as containing the daily amount of fluoride recommended by the American Dental Association, the vitamins actually contained only half the recommended amount. Under the settlement agreement, Qualitest will pay $2.2 million to the federal government and $2.8 million to the state of New York to resolve claims pertaining to New York’s Medicaid program.
Philadelphia business lawyers at the Law Offices of Sidkoff, Pincus & Green have successfully represented clients in whistleblower lawsuits, class actions and business tort litigation for more than 50 years. Contact us online or call our Philadelphia law firm at 215-574-0600.